Litcius/Paper detail

Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective

Xiaoyu Xi, Xin Wang, Wenwen Xie, Jia Yu, Santiago Zuluaga Sanchez, Laura Martínez, Quanming Zhao

2022Cardiovascular Drugs and Therapy14 citationsDOI

Topics & Concepts

EvolocumabMedicineEzetimibeStatinAcute coronary syndromePCSK9Internal medicineQuality-adjusted life yearCost effectivenessMyocardial infarctionCardiologyCholesterolLipoproteinRisk analysis (engineering)LDL receptorApolipoprotein A1Lipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective | Litcius